Cargando…

C-reactive protein is an independent predictor for hepatocellular carcinoma recurrence after liver transplantation

BACKGROUND: Serum C-reactive protein (CRP) is a prognostic factor for overall survival (OS) and recurrence of hepatocellular carcinoma (HCC) in patients treated with resection or non-surgical treatment. Here, we investigated the association of elevated CRP (≥1 vs. <1 mg/dL) with (i) recurrence of...

Descripción completa

Detalles Bibliográficos
Autores principales:	Meischl, Tobias, Rasoul-Rockenschaub, Susanne, Györi, Georg, Sieghart, Wolfgang, Reiberger, Thomas, Trauner, Michael, Soliman, Thomas, Berlakovich, Gabriela, Pinter, Matthias
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2019
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6541257/ https://www.ncbi.nlm.nih.gov/pubmed/31141535 http://dx.doi.org/10.1371/journal.pone.0216677

Ejemplares similares

Alpha‐fetoprotein‐adjusted‐to‐HCC‐size criteria are associated with favourable survival after liver transplantation for hepatocellular carcinoma
por: Meischl, Tobias, et al.
Publicado: (2021)

Antibiotic Therapy is Associated with Worse Outcome in Patients with Hepatocellular Carcinoma Treated with Sorafenib
por: Pomej, Katharina, et al.
Publicado: (2021)

The von Willebrand Factor Facilitates Model for End‐Stage Liver Disease–Independent Risk Stratification on the Waiting List for Liver Transplantation
por: Györi, Georg P., et al.
Publicado: (2020)

Early changes in immunoglobulin G levels during immune checkpoint inhibitor treatment are associated with survival in hepatocellular carcinoma patients
por: Balcar, Lorenz, et al.
Publicado: (2023)

COVID-19 pandemic: Impact on the management of patients with hepatocellular carcinoma at a tertiary care hospital
por: Pomej, Katharina, et al.
Publicado: (2021)

Quantitative PCR of INDELs to measure donor‐derived cell‐free DNA—a potential method to detect acute rejection in kidney transplantation: a pilot study
por: Dauber, Eva‐Maria, et al.
Publicado: (2019)

Vascular Complications in Patients with Hepatocellular Carcinoma Treated with Sorafenib
por: Pomej, Katharina, et al.
Publicado: (2020)

Morphometric Analysis of Mast Cells in Tumor Predicts Recurrence of Hepatocellular Carcinoma After Liver Transplantation
por: Rohr‐Udilova, Nataliya, et al.
Publicado: (2021)

Short- and long-term effects of transarterial chemoembolization on portal hypertension in patients with hepatocellular carcinoma
por: Scheiner, Bernhard, et al.
Publicado: (2019)

Multimodality locoregional treatment strategies for bridging HCC patients before liver transplantation
por: Györi, Georg P., et al.
Publicado: (2017)

MELD-Na Alterations on the Liver Transplant Waiting List and Their Impact on Listing Outcome
por: Silberhumer, Gerd R., et al.
Publicado: (2023)

The impact of thyroid hormones on patients with hepatocellular carcinoma
por: Pinter, Matthias, et al.
Publicado: (2017)

Long-term remission in advanced stage hepatocellular carcinoma? A chance for cure?
por: Pinter, Matthias, et al.
Publicado: (2018)

Cancer and liver cirrhosis: implications on prognosis and management
por: Pinter, Matthias, et al.
Publicado: (2016)

The Addition of C‐Reactive Protein and von Willebrand Factor to Model for End‐Stage Liver Disease‐Sodium Improves Prediction of Waitlist Mortality
por: Starlinger, Patrick, et al.
Publicado: (2021)

Cancer and hepatic steatosis
por: Paternostro, R., et al.
Publicado: (2021)

A Multi-Centre Non-Interventional Study to Assess the Tolerability and Effectiveness of Extended-Release Tacrolimus (LCPT) in De Novo Liver Transplant Patients
por: Soliman, Thomas, et al.
Publicado: (2023)

Dysbalanced sex hormone status is an independent predictor of decompensation and mortality in patients with liver cirrhosis
por: Paternostro, Rafael, et al.
Publicado: (2018)

Deviations of the immune cell landscape between healthy liver and hepatocellular carcinoma
por: Rohr-Udilova, Nataliya, et al.
Publicado: (2018)

The impact of COVID-19 on liver transplantation programs in Austria
por: Hartl, Lukas, et al.
Publicado: (2022)

Diet and exercise in NAFLD/NASH: Beyond the obvious
por: Semmler, Georg, et al.
Publicado: (2021)

Programmed cell death protein‐1 (PD‐1)‐targeted immunotherapy in advanced hepatocellular carcinoma: efficacy and safety data from an international multicentre real‐world cohort
por: Scheiner, Bernhard, et al.
Publicado: (2019)

Impact of glutathione peroxidase 4 on cell proliferation, angiogenesis and cytokine production in hepatocellular carcinoma
por: Rohr-Udilova, Nataliya, et al.
Publicado: (2018)

Review article: therapeutic aspects of bile acid signalling in the gut‐liver axis
por: Simbrunner, Benedikt, et al.
Publicado: (2021)

Alpha-1 antitrypsin Pi∗Z allele is an independent risk factor for liver transplantation and death in patients with advanced chronic liver disease
por: Balcar, Lorenz, et al.
Publicado: (2022)

Proton Pump Inhibitor Intake neither Predisposes to Spontaneous Bacterial Peritonitis or Other Infections nor Increases Mortality in Patients with Cirrhosis and Ascites
por: Mandorfer, Mattias, et al.
Publicado: (2014)

C‐reactive protein: An independent predictor for dedifferentiated chondrosarcoma
por: Nemecek, Elena, et al.
Publicado: (2018)

Standardized intraoperative application of an absorbable polysaccharide hemostatic powder to reduce the incidence of lymphocele after kidney transplantation – a prospective trial
por: Burghuber, Christopher K., et al.
Publicado: (2018)

Gut-liver axis signaling in portal hypertension
por: Simbrunner, Benedikt, et al.
Publicado: (2019)

Recent advances in the understanding and management of hepatorenal syndrome
por: Simbrunner, Benedikt, et al.
Publicado: (2021)

Oxidative stress mediates an increased formation of vascular endothelial growth factor in human hepatocarcinoma cells exposed to erlotinib
por: Rohr-Udilova, Nataliya, et al.
Publicado: (2017)

Liver Capsule: FXR agonists against liver disease
por: Fuchs, Claudia D., et al.
Publicado: (2016)

Impact of ultrasound examination shortly after kidney transplantation
por: Schwarz, Christoph, et al.
Publicado: (2017)

Performance of Controlled Attenuation Parameter in Patients with Advanced Chronic Liver Disease and Portal Hypertension
por: Semmler, Georg, et al.
Publicado: (2019)

Impact of farnesoid X receptor single nucleotide polymorphisms on hepatic decompensation and mortality in cirrhotic patients with portal hypertension
por: Semmler, Georg, et al.
Publicado: (2019)

Portal hypertensive gastropathy is associated with iron deficiency anemia
por: Simbrunner, Benedikt, et al.
Publicado: (2020)

Patterns of acute decompensation in hospitalized patients with cirrhosis and course of acute‐on‐chronic liver failure
por: Balcar, Lorenz, et al.
Publicado: (2021)

Impact of ammonia levels on outcome in clinically stable outpatients with advanced chronic liver disease
por: Balcar, Lorenz, et al.
Publicado: (2023)

Impact of more conservative European Society of Cardiology guidelines on the management of patients with acute chest pain
por: Kienbacher, Calvin L., et al.
Publicado: (2021)

C-reactive Protein is an Independent Predictor of Difficult Emergency Cholecystectomy
por: Gregory, Gordon C, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_rpii3b5duc7lr3mc5hfh3o307i